Want to see JP:6034 full AI Analyst Report?
Top Page
MRT Inc.
(6034)
Select Model
Select Model
Rating:61Neutral
Price Target:
¥679.00
▲(7.78% Upside)
Action:Reiterated
Date:08/18/26
The score is primarily supported by a strong, low-leverage balance sheet and improving profitability versus 2024, plus constructive technical momentum (price above key DMAs and positive MACD). Offsetting this are a high valuation (P/E 42.62) and weaker recent fundamentals momentum, including slightly declining TTM revenue and materially lower TTM free cash flow.
Positive Factors
Low leverage and stable equity
Debt-to-equity of about 0.09 and stable equity provide a substantial cushion against financial stress. Improved leverage versus 2024 preserves flexibility to fund operations or investment through changing healthcare-information demand.
Negative Factors
Declining revenue trend
Lower trailing revenue signals that demand or customer expansion is not currently providing reliable top-line momentum. Persistent stagnation could limit operating leverage and make modest profits more vulnerable to cost increases.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and stable equity
Debt-to-equity of about 0.09 and stable equity provide a substantial cushion against financial stress. Improved leverage versus 2024 preserves flexibility to fund operations or investment through changing healthcare-information demand.
Read all positive factors
MRT Inc. (6034) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.56B
Dividend YieldN/A
Average Volume (3M)2.77K
Price to Earnings (P/E)41.9
Beta (1Y)-0.10
Revenue Growth-6.56%
EPS GrowthN/A
CountryJP
Employees307
SectorGeneral
Sector StrengthN/A
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)15.11
Shares Outstanding5,718,600
10 Day Avg. Volume2,910
30 Day Avg. Volume2,770
Financial Highlights & Ratios
PEG Ratio-0.54
Price to Book (P/B)0.76
Price to Sales (P/S)0.84
P/FCF Ratio8.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MRT Inc. Business Overview & Revenue Model
Company Description
MRT Inc. operates a medical information platform. It provides Gaikin, a recruitment service specializing in part-time physicians; career, a job change support service for doctors; re:ray, a one stop outsourcing service; Door., an app to connect ne...
How the Company Makes Money
null...
MRT Inc. Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
78
Positive
Cash Flow
61
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.99B | 4.19B | 4.17B | 5.41B | 8.74B | 4.47B |
| Gross Profit | 2.49B | 2.60B | 2.48B | 3.27B | 5.41B | 3.37B |
| EBITDA | 367.54M | 331.35M | 165.42M | 1.20B | 3.16B | 1.61B |
| Net Income | 81.33M | 55.77M | -309.16M | 518.36M | 2.16B | 774.49M |
Balance Sheet | ||||||
| Total Assets | 6.37B | 6.48B | 6.75B | 6.47B | 8.16B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.53B | 1.67B | 2.61B | 3.78B | 4.89B | 1.01B |
| Total Debt | 439.08M | 552.97M | 1.05B | 641.79M | 875.86M | 1.04B |
| Total Liabilities | 1.62B | 1.83B | 2.12B | 1.76B | 3.67B | 2.69B |
| Stockholders Equity | 4.75B | 4.65B | 4.52B | 4.58B | 4.39B | 2.22B |
Cash Flow | ||||||
| Free Cash Flow | 271.99M | 409.83M | 461.79M | -208.76M | 4.50B | -308.61M |
| Operating Cash Flow | 293.17M | 417.84M | 503.04M | -193.58M | 4.51B | -298.89M |
| Investing Cash Flow | -515.40M | -623.37M | -1.84B | -243.61M | -431.11M | -206.51M |
| Financing Cash Flow | -438.56M | -730.16M | 161.77M | -669.19M | -203.98M | -67.49M |
MRT Inc. Technical Analysis
Negative
630.00
Price Trends
632.60
Positive
628.84
Positive
636.14
Negative
Market Momentum
1.22
Positive
47.39
Neutral
29.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 630 is below the 20-day moving average (MA) of 637.45, below the 50-day MA of 632.60, and below the 200-day MA of 636.14, indicating a neutral trend. The MACD of 1.22 indicates Positive momentum. The RSI at 47.39 is Neutral, neither overbought nor oversold. The STOCH value of 29.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.
MRT Inc. Peers Comparison
UnderperformOutperform
Sector (55)
JP:6034
MRT Inc.
633.00
-77.00
-10.85%
JP:3628
Data Horizon Co., Ltd.
610.00
66.00
12.13%
JP:4438
Welby Inc.
258.00
-72.00
-21.82%
JP:9218
Mental Health Technologies Co. Ltd.
790.00
0.13
0.02%
JP:366A
Wellness Communications Corporation
1,213.00
-273.53
-18.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.